Precursors to invasive pancreatic cancer - PubMed (original) (raw)
Review
Precursors to invasive pancreatic cancer
Anirban Maitra et al. Adv Anat Pathol. 2005 Mar.
Abstract
Pancreatic cancer, once invasive, is almost uniformly fatal. In order to alleviate the dismal prognosis associated with this disease, it is imperative that pancreatic cancer be recognized and treated prior to invasion. Understanding the morphology and biology of precursor lesions of invasive pancreatic cancer has therefore become an issue of paramount importance. In the last decade, significant progress has been in the recognition and appropriate classification of these precursor lesions, and the current review will focus on our state-of-the-art knowledge on this topic. Mucinous cystic neoplasms (MCNs), intraductal papillary mucinous neoplasms (IPMNs), and pancreatic intraepithelial neoplasia (PanIN) encompass the three known morphologically distinct precursors to invasive pancreatic cancer. In addition to discussion of the "classic" precursor entities, this review will also address some of the recent diagnostic controversies for these lesions, in particular features that distinguish IPMNs from PanIN lesions. Finally, the potential clinical impact of recognizing these precursor lesions in the context of early detection of pancreatic cancer will be discussed.
Similar articles
- [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
Ott C, Heinmöller E, Gaumann A, Schölmerich J, Klebl F. Ott C, et al. Med Klin (Munich). 2007 Feb 15;102(2):127-35. doi: 10.1007/s00063-007-1013-8. Med Klin (Munich). 2007. PMID: 17323019 Review. German. - Precursor lesions in pancreatic cancer: morphological and molecular pathology.
Scarlett CJ, Salisbury EL, Biankin AV, Kench J. Scarlett CJ, et al. Pathology. 2011 Apr;43(3):183-200. doi: 10.1097/PAT.0b013e3283445e3a. Pathology. 2011. PMID: 21436628 Review. - Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
Biankin AV, Kench JG, Dijkman FP, Biankin SA, Henshall SM. Biankin AV, et al. Pathology. 2003 Feb;35(1):14-24. Pathology. 2003. PMID: 12701679 Review. - Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N, Ohmuraya M, Ida S, Hashimoto D, Ikuta Y, Chikamoto A, Hirota M, Baba H. Ozaki N, et al. J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):620-7. doi: 10.1007/s00534-012-0587-6. J Hepatobiliary Pancreat Sci. 2013. PMID: 23475261 - Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
Furukawa T, Fujisaki R, Yoshida Y, Kanai N, Sunamura M, Abe T, Takeda K, Matsuno S, Horii A. Furukawa T, et al. Mod Pathol. 2005 Aug;18(8):1034-42. doi: 10.1038/modpathol.3800383. Mod Pathol. 2005. PMID: 15832194
Cited by
- Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications.
Kong X, Li L, Li Z, Xie K. Kong X, et al. Cytokine Growth Factor Rev. 2012 Dec;23(6):343-56. doi: 10.1016/j.cytogfr.2012.06.006. Epub 2012 Jul 1. Cytokine Growth Factor Rev. 2012. PMID: 22749856 Free PMC article. Review. - Quantitative assessment of pancreatic cancer precursor lesions in IHC-stained tissue with a tissue image analysis platform.
Aeffner F, Martin NT, Peljto M, Black JC, Major JK, Jangani M, Ports MO, Krueger JS, Young GD. Aeffner F, et al. Lab Invest. 2016 Dec;96(12):1327-1336. doi: 10.1038/labinvest.2016.111. Epub 2016 Oct 24. Lab Invest. 2016. PMID: 27775692 - Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.
Mann KM, Ward JM, Yew CC, Kovochich A, Dawson DW, Black MA, Brett BT, Sheetz TE, Dupuy AJ; Australian Pancreatic Cancer Genome Initiative; Chang DK, Biankin AV, Waddell N, Kassahn KS, Grimmond SM, Rust AG, Adams DJ, Jenkins NA, Copeland NG. Mann KM, et al. Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5934-41. doi: 10.1073/pnas.1202490109. Epub 2012 Mar 15. Proc Natl Acad Sci U S A. 2012. PMID: 22421440 Free PMC article. - Prolactin Promotes Fibrosis and Pancreatic Cancer Progression.
Tandon M, Coudriet GM, Criscimanna A, Socorro M, Eliliwi M, Singhi AD, Cruz-Monserrate Z, Bailey P, Lotze MT, Zeh H, Hu J, Goffin V, Gittes GK, Biankin AV, Esni F. Tandon M, et al. Cancer Res. 2019 Oct 15;79(20):5316-5327. doi: 10.1158/0008-5472.CAN-18-3064. Epub 2019 Aug 8. Cancer Res. 2019. PMID: 31395607 Free PMC article. - Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer.
Logsdon CD, Ji B. Logsdon CD, et al. Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S40-3. doi: 10.1016/j.cgh.2009.07.040. Clin Gastroenterol Hepatol. 2009. PMID: 19896097 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical